{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:17:50Z","timestamp":1762521470533},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T00:00:00Z","timestamp":1325116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00228-011-1191-4","type":"journal-article","created":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T09:08:04Z","timestamp":1325063284000},"page":"895-898","source":"Crossref","is-referenced-by-count":35,"title":["Autoimmune hepatitis induced by adalimumab with successful switch to abatacept"],"prefix":"10.1007","volume":"68","author":[{"given":"A.","family":"Grasland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sterpu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boussoukaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,29]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","volume":"9","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Perez-Alvarez R, Diaz-Lagares C, Cuadrado MJ, Khamashta MA (2010) Autoimmune diseases induced by biological agents. A double-edged sword? Autoimmun Rev 9:188\u2013193","journal-title":"Autoimmun Rev"},{"key":"1191_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169\u2013176","journal-title":"Hepatology"},{"key":"1191_CR3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.revmed.2009.05.015","volume":"31","author":"C Corpechot","year":"2010","unstructured":"Corpechot C, Chazouill\u00e8res O (2010) H\u00e9patites auto-immunes: actualit\u00e9s diagnostiques et th\u00e9rapeutiques. Rev Med Int 31:606\u2013614","journal-title":"Rev Med Int"},{"key":"1191_CR4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"1191_CR5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3","volume":"44","author":"G Saleem","year":"2010","unstructured":"Saleem G, Li SC, MacPherson BR, Cooper SM (2010) Hepatitis with interface inflammation and IgG, IgM and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment of the article by Charles et al. Arthritis Rheum 44:1966\u20131967","journal-title":"Arthritis Rheum"},{"key":"1191_CR6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","volume":"64","author":"V Germano","year":"2005","unstructured":"Germano V, Picchianti Diamanti A, Baccano G et al (2005) Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64:1519\u20131520","journal-title":"Ann Rheum Dis"},{"key":"1191_CR7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","volume":"26","author":"GJ Tobon","year":"2007","unstructured":"Tobon GJ, Canas C, Jaller JJ (2007) Serious liver disease induced by infliximab. Clin Rheumatol 26:578\u2013581","journal-title":"Clin Rheumatol"},{"key":"1191_CR8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","volume":"187","author":"G Ozorio","year":"2007","unstructured":"Ozorio G, McGarity B, Bak H et al (2007) Autoimmune hepatitis following infliximab therapy for ankylosing therapy. Med J Aust 187:524\u2013526","journal-title":"Med J Aust"},{"key":"1191_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/RHU.0b013e318188b1df","volume":"14","author":"BM Fathalla","year":"2008","unstructured":"Fathalla BM, Golgsmith DP, Pascasio JM, Baldridge A (2008) Development of autoimmune hepatitis in a child with systemic onset juvenile arthritis during therapy with etanercept. J Clin Rheumatol 14:297\u2013298","journal-title":"J Clin Rheumatol"},{"key":"1191_CR10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10067-008-0885-1","volume":"27","author":"K Harada","year":"2008","unstructured":"Harada K, Akai Y, Koyama S, Ikenaka Y, Saito Y (2008) A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis. Clin Rheumatol 27:1063\u20131066","journal-title":"Clin Rheumatol"},{"key":"1191_CR11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10067-008-1000-3","volume":"27","author":"H Becker","year":"2008","unstructured":"Becker H, Willeke P, Domschke W, Gaubitz M (2008) Etanercept tolerance in a patient with previous infliximab-induced hepatitis. Clin Rheumatol 27:1597\u20131598","journal-title":"Clin Rheumatol"},{"key":"1191_CR12","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/MCG.0b013e3181a745e7","volume":"44","author":"T Adar","year":"2010","unstructured":"Adar T, Mizrahi M, Pappo O, Scheiman-Elazary A, Shibolet O (2010) Adalimumab-induced autoimmune hepatitis. J Clin Gastroenterol 44:e20\u2013e22","journal-title":"J Clin Gastroenterol"},{"key":"1191_CR13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ibd.20293","volume":"14","author":"M Marques","year":"2008","unstructured":"Marques M, Magro F, Cardoso H et al (2008) Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. Inflamm Bowel Dis 14:723\u2013725","journal-title":"Inflamm Bowel Dis"},{"key":"1191_CR14","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2009.02.029","volume":"63","author":"C Goujon","year":"2010","unstructured":"Goujon C, Dahel K, Berard F et al (2010) Autoimmune hepatitis in two psoriasis patients treated with infliximab. J Am Acad Dermatol 63:e43\u2013e44","journal-title":"J Am Acad Dermatol"},{"key":"1191_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.crohns.2010.12.007","volume":"5","author":"A Doyle","year":"2011","unstructured":"Doyle A, Forbes G, Kontorinis N (2011) Autoimmune hepatitis during infliximab therapy for Crohn\u2019s disease: a case report. J Crohns Colitis 5:253\u2013255","journal-title":"J Crohns Colitis"},{"key":"1191_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.2008.03088.x","volume":"34","author":"DA Fairhurst","year":"2009","unstructured":"Fairhurst DA, Sheehan-Dare R (2009) Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriasis. Clin Exp Dermatol 34:421\u2013422","journal-title":"Clin Exp Dermatol"},{"key":"1191_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/11586210-000000000-00000","volume":"24","author":"M Cravo","year":"2010","unstructured":"Cravo M, Silva R, Serrano M (2010) Autoimmune hepatitis induced by infliximab in a patient with Crohn\u2019s disease with no relapse after switching to adalimumab. BioDrugs 24:25\u201327","journal-title":"BioDrugs"},{"key":"1191_CR18","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","volume":"56","author":"DA Goldfeld","year":"2011","unstructured":"Goldfeld DA, Verna EC, Lefkowitch J, Swaminath A (2011) Infliximab-induced autoimmune hepatitis with successful switch to adalimimab in a patient with Crohn\u2019s disease: the index case. Dig Dis Sci 56:3386\u20133388","journal-title":"Dig Dis Sci"},{"key":"1191_CR19","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","volume":"17","author":"K Subramaniam","year":"2011","unstructured":"Subramaniam K, Chitturi S, Brown M, Pavli P (2011) Infliximab-induced autoimmune hepatitis in Crohn\u2019s disease treated with budesonide and mycophenolate. Inflamm Bowel Dis 17:E149\u2013E150","journal-title":"Inflamm Bowel Dis"},{"key":"1191_CR20","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S et al (2010) Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 51:2040\u20132048","journal-title":"Hepatology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1191-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1191-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1191-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T12:32:36Z","timestamp":1593433956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1191-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,29]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1191-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,29]]}}}